Augustine Therapeutics
@augustinetx.com
Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
Augustine Therapeutics's Company Logos
Augustine Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#8627FF
Electric Violet
134, 39, 255
266, 100, 58
47, 85, 0, 0
#F6F5F2
Pampas
246, 245, 242
45, 18, 96
0, 0, 2, 4
#1E1A35
Mirage
30, 26, 53
249, 34, 15
43, 51, 0, 79
About Augustine Therapeutics
Augustine Strange is an innovative brand that specializes in providing groundbreaking therapies for neuromuscular and neurodegenerative diseases. Founded in 2019 as a spin-off of VIB and KU Leuven, Augustine Therapeutics is dedicated to developing a portfolio of first-in-class therapies for rare neuromuscular diseases and neurodegenerative disorders. Their approach is built upon the cutting-edge neurological research conducted by Prof.
Ludo Van Den Bosch, Prof. Joris De Wit, and Prof. Bart De Strooper.
By leveraging new insights into the neuroprotective potential of small-molecule HDAC6 inhibitors, Augustine Therapeutics aims to revolutionize the treatment of conditions such as Charcot-Marie-Tooth (CMT) disease. With a focus on deepening their understanding of CMT biology and characterizing the potential protective action of HDAC6 inhibitors, Augustine Strange is at the forefront of advancements in the field. Their dedication to pushing boundaries and developing innovative therapies sets them apart in the medical community
Company type
Privately Held
Year founded
2019
Company size
11-50 employees
